BMJ Group Logo

Four fifths of NHS trusts still using pen and paper for record keeping

A paper-free NHS remains a distant reality, suggests BMJ analysis Twenty-five years after the government's first push to digitise the NHS, an investigation by The BMJ reveals that only about a fifth of hospital trusts in England are using fully electronic systems for clinical record-keeping. Responses to freedom of information (FOI) requests show that just 39 ...

2026-08-05T16:24:42+01:006 August 2026|Press release, The BMJ|

GLP-1 drug linked to heart benefits for high-risk patients

Findings from clinical practice will help inform shared decision making Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds ...

2026-08-05T16:21:54+01:006 August 2026|Press release, The BMJ|

Antihistamines likely offer no meaningful benefit for eczema and may increase harms

Review addresses longstanding uncertainty around antihistamines for eczema Researchers advise against routine use and call for updated guidance  Adding oral antihistamines to existing eczema treatments is unlikely to lead to clinically important reductions in eczema and itch severity, and may not reduce sleep disturbance or flare-ups, finds a review of the ...

2026-07-29T16:56:51+01:0030 July 2026|Press release, The BMJ|

GLP-1 diabetes drugs linked to increased risk of hair loss

Absolute risk low, but findings may help inform treatment decisions, say researchers  Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, finds a study published by The BMJ today. Although the absolute ...

2026-07-23T10:18:49+01:0023 July 2026|Press release, The BMJ|

Adolescent social media restrictions may reduce some harms while shifting others, warn experts

Effects are not simple and need to be considered within social, technological, commercial, and political contexts to avoid unintended harms As the UK plans to ban under 16s from social media platforms such as Snapchat, TikTok, Instagram, Facebook, and X, experts writing in The BMJ today argue that restrictions may reduce some harms ...

2026-07-15T17:06:40+01:0016 July 2026|Press release, The BMJ|

Epidurals not linked to increased harm for newborns or children

Study provides strong evidence that epidural analgesia in labour is safe for newborns, say researchers Having an epidural during labour is not associated with clinically significant increased risks of harm to newborn babies, including brain injury, severe breathing problems, sepsis and death, or cerebral palsy later in childhood. The researchers ...

2026-07-15T17:04:34+01:0016 July 2026|Press release, The BMJ|

Most obesity drugs do not improve quality of life or heart health

Treatment decisions should be individualised, balancing expected benefits, harms, treatment burden, costs, availability, and patient preferences, say researchers Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life and few show cardiovascular benefits at one year, finds an analysis of the latest evidence published ...

2026-07-08T15:52:46+01:009 July 2026|Press release, The BMJ|

Mechanical restraint linked to small increased short term blood clot risk in psychiatric hospitals

Absolute risk is low, but findings support ongoing efforts to reduce use and duration of mechanical restraint where feasible Mechanical restraint is associated with a small increased short term risk of blood clots among inpatients at psychiatric hospitals, finds a Danish study published by The BMJ today. Although the absolute risk remains ...

2026-07-01T16:28:35+01:002 July 2026|Press release, The BMJ|
Go to Top